Compound Docking

  • Check with publisher
  • Published date: January 10, 2019
    • Shirley, New York, United States

Compound docking is a computer simulation procedure to predict the conformation of a receptor-ligand complex. Only when the structure of a target and its active or binding site are available, high-throughput docking is chiefly used as a hit identification tool. Also, similar calculations are often used later on during lead optimization when modifications to known active structures can quickly be tested in computer models before compound synthesis. Furthermore, docking can also contribute to the analysis of drug metabolism using structures. The docking process involves the prediction of ligand conformation and orientation (or posing) within a targeted binding site. In general, there are two aims of docking studies: accurate structural modeling and correct prediction of activity.

BOC Sciences is the industry-leading expert in compound docking and our rich experience enables us to provide comprehensive services. https://www.bocsci.com/solutions/compound-docking.htm

Result 0 votes
Alex Brown
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Human anti-OVA (aa324-337) T cell receptor, pCDTCR1

    Human anti-OVA (aa324-337) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-OVA T cell receptor (TCR) is constructed for the engineering of T cell to target OVA. The T cells are genetically modified through transduction with a retroviral vector expressing OVA-specific T cell receptor. And the vector produc...

  • Human anti-OVA (aa325-340) T cell receptor, pCDTCR1

    Human anti-OVA (aa325-340) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-OVA T cell receptor (TCR) is constructed for the engineering of T cell to target OVA. The T cells are genetically modified through transduction with a retroviral vector expressing OVA-specific T cell receptor. And the vector produc...

  • Human anti-NY-ESO-1 (aa117-139) T cell receptor, pCDTCR1

    Human anti-NY-ESO-1 (aa117-139) T cell receptor, pCDTCR1

    Cell Biology & Microbiology Shirley (New York) January 31, 2020 1.00 Dollar US$

    The vector of anti-NY-ESO-1 T cell receptor (TCR) is constructed for the engineering of T cell to target Human NY-ESO-1. The T cells are genetically modified through transduction with a retroviral vector expressing NY-ESO-1-specific T cell receptor. ...